Janus kinases inhibitors for coronavirus disease-2019: A pairwise and Bayesian network meta-analysis

Janus kinases inhibitors for coronavirus disease-2019: A pairwise and Bayesian network meta-analysis

BackgroundJAK (Janus kinases) inhibitors have been proposed as a promising treatment option for the coronavirus disease-2019 (COVID-19). However, the benefits of JAK inhibitors and the optimum thereof for COVID-19 have not been adequately defined.MethodsDatabases were searched from their inception d...

Full description

Bibliographic Details
Main Authors: Jianyi Niu, Zhiwei Lin, Zhenfeng He, Xiaojing Yang, Lijie Qin, Shengchuan Feng, Lili Guan, Luqian Zhou, Rongchang Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Medicine
Subjects:
COVID-19
JAK inhibitors
mortality
adverse events
network meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.973688/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.973688/full

Similar Items